🎗️ OncologyInjectable
Carmustine
carmustine
Nitrosourea alkylating agent used as palliative therapy for brain tumors, multiple myeloma, Hodgkin disease, and non-Hodgkin lymphomas.
Form
Injectable
Uses
3
Side effects
4
Category
Oncology
01
What is Carmustine used for?
- Palliative treatment of brain tumors including glioblastoma multiforme
- Treatment of multiple myeloma and Hodgkin disease
- Treatment of non-Hodgkin lymphomas refractory to primary therapy
02
carmustine side effects
Common side effects of carmustine include:
Bone marrow suppression
Nausea and vomiting
Pulmonary fibrosis
Hepatotoxicity
CommonModerateLess common
03
carmustine warnings & precautions
- Delayed bone marrow suppression can occur 4 to 6 weeks after a dose
- Monitor pulmonary function; risk of pulmonary fibrosis increases with cumulative dose
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Carmustine in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.